Home > > North America And Global Rare Disease Treatment Market- Size, Share, Growth Rate, and Forecast
The North America Rare Disease Treatment market was valued at $80,935.4 Million in 2023, and is projected to reach $171,494.8 Million by 2030 growing at a CAGR of 11.37% from 2024 to 2030. Biologics segment is expected to be the highest contributor to this market, with $70,252.0 Million in 2023, and is anticipated to reach $148,762.3 by 2030, registering a CAGR of 11.36%. Non-biologics segment is anticipated to reach $22,732.4 Million by 2030 with the highest CAGR of 11.44%. Drug type Biologics Non-biologics Therapeutic Area Cancer Blood-related Disorders Central Nervous System (CNS) Respiratory Disorders Musculoskeletal Disorders Cardiovascular Disorders Other Therapeutic Areas Patient Adult Pediatric Route of Administration Oral Injectable BY REGION North America U.s. Canada Mexico Europe Germany France UK Italy Spain Russia Rest of Europe Asia China India Japan Australia South Korea Rest of Asia Middle East & Africa Brazil South Africa GCC Rest of MENA